Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Page 1
Tailored anticoagulant treatment after a first venous thromboembolism: protocol of the Leiden Thrombosis Recurrence Risk Prevention (L-TRRiP) study - cohort-based randomised controlled trial.
Burggraaf-van Delft JLI, van Rein N, Bemelmans RHH, van den Berg JK, Bruggeman CY, Cloos-van Balen M, Coppens M, Eefting M, Ende-Verhaar Y, van Es N, van Guldener C, de Jong WK, Kleijwegt F, Koster T, Kroon C, Kuipers S, Leentjens J, Luijten D, Mairuhu ATA, Meijer K, van de Ree MA, Roos R, Schrover I, Swart-Heikens J, van der Velden AWG, van den Akker-van Marle EM, le Cessie S, Geersing GJ, Middeldorp S, Huisman MV, Klok FA, Cannegieter SC; L-TRRiP investigators. Burggraaf-van Delft JLI, et al. Among authors: klok fa. BMJ Open. 2024 Mar 23;14(3):e078676. doi: 10.1136/bmjopen-2023-078676. BMJ Open. 2024. PMID: 38521524 Free PMC article.
The aim of the Leiden Thrombosis Recurrence Risk Prevention (L-TRRiP) study is to evaluate the outcomes of tailored duration of long-term anticoagulant treatment based on individualised assessment of rVTE and major bleeding risks. ...
The aim of the Leiden Thrombosis Recurrence Risk Prevention (L-TRRiP) study is to evaluate the outcomes of tailored duration of long-term …
Symptom-related screening programme for early detection of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the SYSPPE study.
Marin-Romero S, Ballaz-Quincoces A, Gómez-Cuervo C, Marchena-Yglesias PJ, Lopez-Miguel P, Francisco-Albesa I, Pedrajas-Navas JM, Lumbierres M, Aibar-Arregui MA, Bosco Lopez-Saez J, Perez-Pinar M, Baeza-Martinez C, Riera-Mestre A, Peris-Sifre M, Porras-Ledantes JA, Criado-Garcia J, Elias-Hernandez T, Otero R, Barca-Hernando M, Muriel A, Klok FA, Jara-Palomares L; SYSPPE investigators. Marin-Romero S, et al. Among authors: klok fa. Thorax. 2024 Jan 18;79(2):144-152. doi: 10.1136/thorax-2023-220580. Thorax. 2024. PMID: 38050187 Free PMC article.
BACKGROUND: Chronic thromboembolic pulmonary hypertension (CTEPH) is the most severe long-term complication of acute pulmonary embolism (PE). We aimed to evaluate the impact of a symptom screening programme to detect CTEPH in PE survivors. ...
BACKGROUND: Chronic thromboembolic pulmonary hypertension (CTEPH) is the most severe long-term complication of acute pulmonary emboli …
Comparison of important factors to patients recovering from pulmonary embolism and items covered in patient-reported outcome measures: A mixed-methods systematic review.
Ingemann-Molden S, Caspersen CK, Rolving N, Højen AA, Klok FA, Grove EL, Brocki BC, Andreasen J. Ingemann-Molden S, et al. Among authors: klok fa. Thromb Res. 2024 Jan;233:69-81. doi: 10.1016/j.thromres.2023.11.013. Epub 2023 Nov 23. Thromb Res. 2024. PMID: 38029548 Free article. Review.
OBJECTIVE: Up to 50 % of patients recovering from pulmonary embolism (PE) experience negative long-term outcomes. Patient-reported outcome measures (PROMs) are important in identifying what matters to patients. ...
OBJECTIVE: Up to 50 % of patients recovering from pulmonary embolism (PE) experience negative long-term outcomes. Patient-reported ou …
Health-related quality of life after first venous thromboembolism in individuals aged 70 years and older.
Wang H, Klok FA, Rosendaal FR, Cushman M, van Hylckama Vlieg A. Wang H, et al. Among authors: klok fa. Res Pract Thromb Haemost. 2023 Jun 30;7(5):102144. doi: 10.1016/j.rpth.2023.102144. eCollection 2023 Jul. Res Pract Thromb Haemost. 2023. PMID: 37601012 Free PMC article.
BACKGROUND: There is limited information on short- and long-term effects of venous thromboembolism (VTE) on health-related quality of life (HRQoL) in the elderly. ...CONCLUSION: Overall, the quality of life of patients with VTE was worse than that of controls after 1 year, …
BACKGROUND: There is limited information on short- and long-term effects of venous thromboembolism (VTE) on health-related quality of …
Diagnostic management of acute pulmonary embolism: a prediction model based on a patient data meta-analysis.
van Es N, Takada T, Kraaijpoel N, Klok FA, Stals MAM, Büller HR, Courtney DM, Freund Y, Galipienzo J, Le Gal G, Ghanima W, Huisman MV, Kline JA, Moons KGM, Parpia S, Perrier A, Righini M, Robert-Ebadi H, Roy PM, Wells PS, de Wit K, van Smeden M, Geersing GJ. van Es N, et al. Among authors: klok fa. Eur Heart J. 2023 Aug 22;44(32):3073-3081. doi: 10.1093/eurheartj/ehad417. Eur Heart J. 2023. PMID: 37452732 Free PMC article.
The final model included age (in years), sex, previous VTE, recent surgery or immobilization, haemoptysis, cancer, clinical signs of deep vein thrombosis, inpatient status, D-dimer (in g/L), and an interaction term between age and D-dimer. The pooled c-statistic was 0.87 ( …
The final model included age (in years), sex, previous VTE, recent surgery or immobilization, haemoptysis, cancer, clinical signs of deep ve …
Use of patient-reported outcome measures in patients with venous thromboembolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease.
de Jong CMM, de Wit K, Black SA, Gwozdz AM, Masias C, Parks AL, Robert-Ebadi H, Talerico R, Woller SC, Klok FA. de Jong CMM, et al. Among authors: klok fa. J Thromb Haemost. 2023 Oct;21(10):2953-2962. doi: 10.1016/j.jtha.2023.06.023. Epub 2023 Jun 30. J Thromb Haemost. 2023. PMID: 37394119 Free article.
After pulmonary embolism or deep vein thrombosis, patients may face a broad spectrum of complications and long-term sequelae beyond the usual quality-of-care indicators of recurrent venous thromboembolism (VTE), bleeding complications, and survival. ...
After pulmonary embolism or deep vein thrombosis, patients may face a broad spectrum of complications and long-term sequelae beyond t …
Therapeutic anticoagulation for splanchnic vein thrombosis in acute pancreatitis: A national survey and case-vignette study.
Sissingh NJ, Groen JV, Timmerhuis HC, Besselink MG, Boekestijn B, Bollen TL, Bonsing BA, Klok FA, van Santvoort HC, Verdonk RC, van Eijck CHJ, van Hooft JE, Mieog JSD. Sissingh NJ, et al. Among authors: klok fa. World J Gastroenterol. 2023 Jun 7;29(21):3328-3340. doi: 10.3748/wjg.v29.i21.3328. World J Gastroenterol. 2023. PMID: 37377583 Free PMC article.
Agreement was lacking regarding the selection and duration of long-term anticoagulation, the indication for thrombophilia testing and upper endoscopy, and about whether risk of bleeding is a major barrier for therapeutic anticoagulation. ...
Agreement was lacking regarding the selection and duration of long-term anticoagulation, the indication for thrombophilia testing and …
Long-Term Prognostic Impact of Pulmonary Hypertension After Venous Thromboembolism.
Bonnesen K, Klok FA, Andersen MJ, Andersen A, Nielsen-Kudsk JE, Mellemkjær S, Sørensen HT, Schmidt M. Bonnesen K, et al. Among authors: klok fa. Am J Cardiol. 2023 Jul 15;199:92-99. doi: 10.1016/j.amjcard.2023.04.023. Epub 2023 May 16. Am J Cardiol. 2023. PMID: 37202325 Free article.
We examined the impact of CTEPH and other pulmonary hypertension (PH) subtypes on long-term mortality after VTE. We conducted a nationwide, population-based cohort study of all adult Danish patients alive 2 years after incident VTE without previous PH from 1995 to 2020 (n …
We examined the impact of CTEPH and other pulmonary hypertension (PH) subtypes on long-term mortality after VTE. We conducted a natio …
Chronic thromboembolic pulmonary hypertension and clot resolution after COVID-19-associated pulmonary embolism.
de Jong CMM, Visser C, Bemelmans RHH, Boersma WG, van den Borst B, Burggraaf JLI, Cannegieter SC, Ten Cate-Hoek AJ, Croles FN, Faber HJ, Faber LM, Hellemons ME, Hessels LM, Huisman MV, Kamphuisen PW, Koster SCE, Kroft LJM, van der Lee I, Leentjens J, Meijer K, Ninaber MK, Sondermeijer BM, Stads S, Vonk Noordegraaf A, Winckers K, Kruip MJHA, Klok FA; Dutch COVID & Thrombosis Coalition investigators. de Jong CMM, et al. Among authors: klok fa. Eur Respir J. 2023 Apr 20;61(4):2300171. doi: 10.1183/13993003.00171-2023. Print 2023 Apr. Eur Respir J. 2023. PMID: 37080574 Free PMC article.
The results of this study suggest that CTEPH is not a more common long-term complication after COVID-19-associated PE than after PE in non-COVID-19 patients, and thrombus resolution did not seem to be different from non-COVID-19-associated PE https://bit.ly/3IjvWL3 The inc …
The results of this study suggest that CTEPH is not a more common long-term complication after COVID-19-associated PE than after PE i …
The Post-Venous Thromboembolism Functional Status Scale: From Call to Action to Application in Research, Extension to COVID-19 Patients, and Its Use in Clinical Practice.
de Jong CMM, Boon GJAM, Le YNJ, Barco S, Siegerink B, Klok FA. de Jong CMM, et al. Among authors: klok fa. Semin Thromb Hemost. 2023 Oct;49(7):764-773. doi: 10.1055/s-0043-1764467. Epub 2023 Mar 20. Semin Thromb Hemost. 2023. PMID: 36940713 Review.
A broad spectrum of long-term sequelae may be present in venous thromboembolism (VTE) survivors, affecting their quality of life and functioning. ...
A broad spectrum of long-term sequelae may be present in venous thromboembolism (VTE) survivors, affecting their quality of life and …
59 results